Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1978
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: well documented, contributing to assessment

Data source

Reference
Reference Type:
publication
Title:
Comparative studies of chromosomal aberration and mutagenicity of the trivalent and hexavalent chromium.
Author:
Nakamuro K, Yoshikawa K, Sayato Y, Kurata H
Year:
1978
Bibliographic source:
Mutation Research, 58:175–181.
Report date:
1978

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
Deviations:
not specified
GLP compliance:
no
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
Chromium trichloride
EC Number:
233-038-3
EC Name:
Chromium trichloride
Cas Number:
10025-73-7
Molecular formula:
Cl3Cr
IUPAC Name:
chromium trichloride
Test material form:
not specified
Details on test material:
CrCl3 was supplied by Wako Pure Chemmals Co. Ltd., Tokyo. The chromium compounds was dissolved m water. When necessary, 1 M NaOH or 1 M HC1 solution was added.

Method

Target gene:
Human leukocytes
Species / strain
Species / strain / cell type:
other: Human leukocytes
Additional strain / cell type characteristics:
not specified
Metabolic activation:
not specified
Test concentrations with justification for top dose:
32×10E-6M
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
not specified
True negative controls:
not specified
Positive controls:
not specified
Details on test system and experimental conditions:
Peripheral blood was obtained from a normal healthy man. Human leukocytes were cultured for 72 h according to the method already described.
CrCl3 was added to the leukocyte culture 24 h before the 4-h prefixation treatment with colchicine. Chromosome preparations were made by the standard flame-drying method.

Results and discussion

Test results
Species / strain:
other: Human leukocytes
Metabolic activation:
not specified
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
not specified
Vehicle controls validity:
not specified
Untreated negative controls validity:
valid
Positive controls validity:
not specified
Additional information on results:
Leukocyte cultures were treated with chromium compounds at random throughout the cell cycle; the frequency of structural chromosomal aberrations was given. When cultures were treated by the same concentration (32 × 10E-6 M) of each chromium compound, the karyotype of chromosome was not observed after treatment with compounds such as K2Cr207 and K2CrO4. In cultures treated with higher concentrations of chromium, a significant number of structural aberrations was observed compared with those in the control culture.
As chromium compounds had strong cytotoxiclty and comparatively high activity for chromosome damage, leukocytes were next exposed to lower concentrations near the natural level of chromium.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

Under this experimental conditions provide in this report, chromium trichloride did not induce positive clastogenic effects.
Executive summary:

This report was published to investigate chromosomal aberrations in human leukocyte cultures with compounds containing Cr 3+ including Cr(NO3)3, Cr(OOCCH3)3 and CrCl3, but also with K2CrO4 and K2Cr2O7. Peripheral blood was obtained from a normal healthy man. Human leukocytes were cultured for 72 h. Chromium compounds were added to the leukocyte culture 24 h before the 4-h prefixation treatment with colchicine. There was no significant difference between test and control cultures in the aberrations with breaks and exchanges or total aberrations, when CrCl3 was tested. In a comparison of the total aberration yield on an equimolar basis, the efficiency in inducing chromosomal aberrations was in the order K2Cr2O7 > K2CrO4 > > Cr(CH3COO)3 > Cr(NO3)3, CrCl3. The last three compounds containing trivalent chromium were significantly less efficient as compared with the first two hexavalent chromium compounds.